$0.7513
-0.0138-1.80%
At close: Aug 5, 5:00 PM EST
$0.7700
0.01872.49%
After Hours: 4:45 PM EST
Artelo Biosciences Inc Earnings Estimates
ARTLNASDAQ
Artelo Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:ARTL
Artelo Biosciences (ARTL) is scheduled to report Q2 earnings on August 17, 2026.
In the most recent quarter (Q1), Artelo Biosciences reported EPS of $-4.00, missing estimates of $-1.57 by 1.55%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Over the last 4 quarters, Artelo Biosciences has averaged an EPS surprise of 1.90% and a revenue surprise of 0.00%.
Earnings Date
May 14
EPS
$-4.000
Quarterly Revenue
$0
Annual Revenue
–
as of Mar 31
Artelo Biosciences Earnings History
Analyze the earnings history of Artelo Biosciences using advanced sorting and filters.
Artelo Biosciences (ARTL) Earnings Per Share
The chart below shows Artelo Biosciences's reported EPS compared to analyst estimates over recent quarters.
Artelo Biosciences (ARTL) Revenue
The chart below shows Artelo Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?
Artelo Biosciences (ARTL) is scheduled to report earnings on August 17, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Artelo Biosciences (NASDAQ:ARTL)?
The Actual EPS was $-4.00, which missed the estimate of $-1.57.
What were Artelo Biosciences’s (NASDAQ:ARTL) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
